« Home | Big Pharma Research Racket Is Killing People » | Human Genome Sciences Wins Government Deal Worth $... » | Vaccines May Have Caused a Soldiers' Death » | DoD to Continue Smallpox Vaccinations Despite Sold... » | Military Smallpox Vaccine May Have Killed Soldier » | Pentagon says vaccine may have killed US soldier » | Human Genome gets U.S. contract - Government to pu... » | U.S. to Buy Anthrax Treatment » | Former HHS secretary named to Emergent board » | Calculating U.S. Influenza Deaths »


New York Times

Emergent BioSolutions sells only one product, an anthrax vaccine called BioThrax, to only one customer, the federal government. So when it went looking for someone to fill a board seat, it had some very specific qualifications in mind.

Dr. Louis W. Sullivan meets them all. A physician who is president emeritus of the Morehouse School of Medicine in Atlanta, he serves on the boards of similar companies.

He also ran the Department of Health and Human Services from 1989 to 1993. That agency and the Department of Defense buy all of Emergent's vaccines. At least for now.

To expand, the company is trying to sign up states and cities, said Kyle W. Keese, its senior vice president for marketing. That is where another director, Jerome M. Hauer, comes in handy. He ran New York City's Office of Emergency Management under former Mayor Rudolph W. Giuliani.